Clinical Trial Update: A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing anidulafungin to fluconazole for candidemia and invasive candidiasis was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Diflucan (Fluconazole)
• Eraxis (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidemia | Phase 3 | Status: TERMINATED | Results posted: 2015-09-21